121 related articles for article (PubMed ID: 445320)
1. 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for adenocarcinoma of the lung.
Butler TP; MacDonald JS; Smith FP; Smith LF; Woolley PV; Schein PS
Cancer; 1979 Apr; 43(4):1183-8. PubMed ID: 445320
[TBL] [Abstract][Full Text] [Related]
2. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer.
MacDonald JS; Woolley PV; Smythe T; Ueno W; Hoth D; Schein PS
Cancer; 1979 Jul; 44(1):42-7. PubMed ID: 455263
[TBL] [Abstract][Full Text] [Related]
3. 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas.
Smith FP; Hoth DF; Levin B; Karlin DA; MacDonald JS; Woolley PV; Schein PS
Cancer; 1980 Nov; 46(9):2014-8. PubMed ID: 7427908
[TBL] [Abstract][Full Text] [Related]
4. 5-fluorouracil, adriamycin, and mitomycin-C (Hi-FAM) chemotherapy for adenocarcinoma of the lung.
Rosi DR; Nogeire C; Brown B; Ali M; Ewer M; Samuels M
Cancer; 1981 Jul; 48(1):21-5. PubMed ID: 7237386
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung.
Shepherd FA; Evans WK; Burkes R; Paul K; DeBoer G
Am J Clin Oncol; 1986 Oct; 9(5):392-6. PubMed ID: 3776901
[TBL] [Abstract][Full Text] [Related]
6. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules.
Lam WK; So SY; Kung TM; Sham MK; Ip M
Cancer Chemother Pharmacol; 1987; 19(3):269-71. PubMed ID: 3107849
[TBL] [Abstract][Full Text] [Related]
7. 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.
MacDonald JS; Schein PS; Woolley PV; Smythe T; Ueno W; Hoth D; Smith F; Boiron M; Gisselbrecht C; Brunet R; Lagarde C
Ann Intern Med; 1980 Oct; 93(4):533-6. PubMed ID: 7436184
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas.
Sulkes A; Uziely B; Isacson R; Brufman G; Biran S
Isr J Med Sci; 1988; 24(9-10):604-10. PubMed ID: 3204009
[TBL] [Abstract][Full Text] [Related]
9. [5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland].
Inoue K; Horikoshi N; Mukaiyama T; Ogawa M; Kuraishi Y
Gan No Rinsho; 1989 Mar; 35(4):481-5. PubMed ID: 2654442
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma.
Bukowski RM; Schacter LP; Groppe CW; Hewlett JS; Weick JK; Livingston RB
Cancer; 1982 Jul; 50(2):197-200. PubMed ID: 6211223
[TBL] [Abstract][Full Text] [Related]
11. Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C.
Cunningham D; Soukop M; McArdle CS; Carter DC; Smyth JF; Allan SG; Kaye SB; Sangster G; Calman KC; Hutcheon AW
Br J Surg; 1984 Sep; 71(9):673-6. PubMed ID: 6548166
[TBL] [Abstract][Full Text] [Related]
12. Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM).
Haim N; Epelbaum R; Cohen Y; Robinson E
Cancer; 1984 Nov; 54(9):1999-2002. PubMed ID: 6548173
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary.
Treat J; Falchuk SC; Tremblay C; Spielman M; Woolley PV; Rouesse J; Sevin D; Le Chevalier T
Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1053-5. PubMed ID: 2759160
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil, doxorubicin, and mitomycin-C in the treatment of adenocarcinoma and large cell carcinoma of the lung.
Shaw MT; Shaw MK
Cancer; 1987 Sep; 60(6):1190-3. PubMed ID: 3040207
[TBL] [Abstract][Full Text] [Related]
15. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).
Bitran JD; Desser RK; Kozloff MF; Billings AA; Shapiro CM
Cancer Treat Rep; 1979; 63(11-12):2049-51. PubMed ID: 393388
[TBL] [Abstract][Full Text] [Related]
16. MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas.
Sternberg CN; Magill GB; Sordillo PP; Cheng EW
Am J Clin Oncol; 1984 Oct; 7(5):529-33. PubMed ID: 6391145
[TBL] [Abstract][Full Text] [Related]
17. 5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary.
Goldberg RM; Smith FP; Ueno W; Ahlgren JD; Schein PS
J Clin Oncol; 1986 Mar; 4(3):395-9. PubMed ID: 3754004
[TBL] [Abstract][Full Text] [Related]
18. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.
Theodors A; Bukowski RM; Hewlett JS; Livingston RB; Weick JK
Am J Clin Oncol; 1982 Oct; 5(5):555-8. PubMed ID: 6217742
[TBL] [Abstract][Full Text] [Related]
19. Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma.
Salvati F; Cruciani AR; De Marinis A; Nunziati F; Portalone L
Jpn J Clin Oncol; 1984 Mar; 14(1):3-6. PubMed ID: 6323790
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
